148 related articles for article (PubMed ID: 922745)
41. Relationship between plasma progesterone, estradiol and prolactin concentrations and breast cancer in pre and postmenopausal women.
Raheem SN; Atoum M; Al-Hourani H; Rasheed M; Nimer N; Almuhrib T
Neoplasma; 2010; 57(1):74-8. PubMed ID: 19895176
[TBL] [Abstract][Full Text] [Related]
42. Hormone concentrations in postmenopausal patients with breast cancer.
Jones MK; Ramsay ID; Booth M; Collins WP
Clin Oncol; 1977 Jun; 3(2):177-81. PubMed ID: 872471
[No Abstract] [Full Text] [Related]
43. The relationship between blood prolactin levels and risk of breast cancer in premenopausal women.
Wang DY; de Stavola BL; Bulbrook RD; Allen DS; Kwa HG; Verstraeten AA; Moore JW; Fentiman IS; Chaudary M; Hayward JL
Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1541-8. PubMed ID: 3678318
[TBL] [Abstract][Full Text] [Related]
44. Plasma prolactin levels in patients with breast cancer.
Rose DP; Pruitt BT
Cancer; 1981 Dec; 48(12):2687-91. PubMed ID: 7306924
[TBL] [Abstract][Full Text] [Related]
45. [Pre- and postoperative differences in the circadian secretion of prolactin in carcinoma of the human breast].
Larrad Jiménez A; Caballero Asensi A; López Lazareno N
Rev Esp Oncol; 1983; 30(2):139-69. PubMed ID: 6680777
[TBL] [Abstract][Full Text] [Related]
46. Plasma lipids and prolactin in patients with breast cancer.
Bani IA; Williams CM; Boulter PS; Dickerson JW
Br J Cancer; 1986 Sep; 54(3):439-46. PubMed ID: 3756079
[TBL] [Abstract][Full Text] [Related]
47. Circadian study of immunoreactive prolactin in patients with cirrhosis of the liver.
Tarquini B; Gheri R; Anichini P; Neri B; Buricchi L
Gastroenterology; 1977 Jul; 73(1):116-9. PubMed ID: 863182
[TBL] [Abstract][Full Text] [Related]
48. Prolactin levels in populations at risk for breast cancer.
Hill P; Wynder EL; Kumar H; Helman P; Rona G; Kuno K
Cancer Res; 1976 Nov; 36(11 Pt 1):4102-6. PubMed ID: 975051
[TBL] [Abstract][Full Text] [Related]
49. [Evaluation of functional periodicity of the pituitary gland by harmonic analysis.--IV) Circadian prolactin secretion in women with breast cancer].
Zauli C; Murialdo G; Piscopo R; Santoni O; Calzia R; Giovale M
Boll Soc Ital Biol Sper; 1983 Apr; 59(4):462-8. PubMed ID: 6882541
[TBL] [Abstract][Full Text] [Related]
50. Plasma prolactin levels in women at postmenopausal age with a family history of breast cancer or a prescription for antihypertensive Rauwolfia treatment.
de Waard F; Kwa HG; Poortman J
Oncology; 1980; 37(1):33-6. PubMed ID: 7350553
[TBL] [Abstract][Full Text] [Related]
51. Abnormalities in evening plasma prolactin levels in nulliparous women with benign or malignant breast disease.
Tarquini A; di Martino L; Malloci A; Kwa HG; van der Gugten AA; Bulbrook RD; Wang DY
Int J Cancer; 1978 Dec; 22(6):687-90. PubMed ID: 721323
[TBL] [Abstract][Full Text] [Related]
52. An abnormal luteal-phase evening peak of plasma prolactin in women with a family history of breast cancer.
Kwa HG; Wang DY
Int J Cancer; 1977 Jul; 20(1):12-4. PubMed ID: 561758
[TBL] [Abstract][Full Text] [Related]
53. Circulating levels of prolactin in human breast cancer.
Sheth NA; Ranadive KJ; Suraiya JN; Sheth AR
Br J Cancer; 1975 Aug; 32(2):160-7. PubMed ID: 2274
[TBL] [Abstract][Full Text] [Related]
54. Plasma prolactin and its relationship to risk factors in human breast cancer.
Kwa HG; Cleton F; de Jong-Bakker M; Bulbrook RD; Hayward JL; Wang DY
Int J Cancer; 1976 Apr; 17(4):441-7. PubMed ID: 945228
[TBL] [Abstract][Full Text] [Related]
55. Prolactin and growth hormone levels in premenopausal women with breast cancer and healthy women with a strong family history of breast cancer.
Love RR; Rose DR; Surawicz TS; Newcomb PA
Cancer; 1991 Sep; 68(6):1401-5. PubMed ID: 1873792
[TBL] [Abstract][Full Text] [Related]
56. Relationship of blood prolactin levels and the risk of subsequent breast cancer.
Wang DY; De Stavola BL; Bulbrook RD; Allen DS; Kwa HG; Fentiman IS; Hayward JL; Millis RR
Int J Epidemiol; 1992 Apr; 21(2):214-21. PubMed ID: 1428472
[TBL] [Abstract][Full Text] [Related]
57. Prolactin response to dopamine and valproate administration in breast cancer patients.
Stalldecker GB; Pigni J; Fuentes AM; Vegh I
Biomed Pharmacother; 1989; 43(4):301-6. PubMed ID: 2506942
[TBL] [Abstract][Full Text] [Related]
58. [Prolactin and cancer of the breast].
Marugo M; Giusti M; Bolognesi F; Reitano A
Boll Soc Ital Biol Sper; 1977 Apr; 53(8):675-8. PubMed ID: 907746
[No Abstract] [Full Text] [Related]
59. [Relationship between benign breast cancer and plasma levels of prolactin].
Strollo F; Perniciaro G; Di Cesare T; Morè M; Marini R; Riondino G
Boll Soc Ital Biol Sper; 1981 Dec; 57(23):2338-44. PubMed ID: 7337747
[TBL] [Abstract][Full Text] [Related]
60. Relation between tumour size and plasma prolactin levels in premenopausal patients with breast carcinoma. A preliminary report.
Olsson H; Ewers SB; Landin-Olsson M; Ranstam J
Acta Radiol Oncol; 1985; 24(1):57-9. PubMed ID: 2984903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
